Merck (MRK) Announces FDA Holds on Studies Evaluating Islatravir for the Treatment and Prevention of HIV-1 Infection
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- US stock futures steady as oil jumps to two-week high ahead of key earnings
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's Russian supply announcements
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- Iren shares jump 5% in premarket trade on report of Anthropic AI cloud deal
| Merck & Co. (NYSE: MRK) | Delayed: 145.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.60 | 52 Week High | $65.46 | |||
| Open | $145.60 | 52 Week Low | $47.97 | |||
| Day High | $145.60 | P/E | 99.05 | |||
| Day Low | $145.60 | EPS | $1.47 | |||
| Volume | 15,412 | |||||
